Recent Quarter Total Invested
$4.32 B
Recent Quarter Institutional Ownership Percentage
105.51%
Total Invested of Last Quarter
$3.69 B
Ownership Percentage of Last Quarter
114.08%
Crinetics Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 6.55 M | $334.70 M | 100.00% | 8.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2024 | 5.89 M | $300.74 M | -3.71% | 7.35% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 4.94 M | $252.68 M | 12.22% | 6.17% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 4.46 M | $227.89 M | -3.48% | 5.57% |
| ECOR1 CAPITAL, LLC | 11/14/2024 | 4.29 M | $219.12 M | 3.19% | 5.35% |
| STATE STREET CORP | 11/14/2024 | 2.84 M | $145.05 M | 0.91% | 3.54% |
| JENNISON ASSOCIATES LLC | 11/08/2024 | 2.79 M | $142.75 M | 0.48% | 3.49% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2024 | 2.52 M | $128.60 M | 0.13% | 3.14% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 2.43 M | $124.13 M | -1.07% | 3.03% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 2.30 M | $117.56 M | -17.27% | 2.87% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.85 M | $94.46 M | 10.11% | 2.31% |
| FRANKLIN RESOURCES INC | 11/12/2024 | 1.39 M | $73.81 M | 61.37% | 1.74% |
| SIREN, L.L.C. | 11/13/2024 | 1.31 M | $66.92 B | 100.00% | 1.64% |
| FARALLON CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.16 M | $59.38 M | 133.80% | 1.45% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2024 | 1.10 M | $56.21 M | -18.52% | 1.37% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2024 | 1.07 M | $54.60 M | -20.69% | 1.33% |
| ORBIMED ADVISORS LLC | 11/14/2024 | 1.05 M | $53.66 M | -18.02% | 1.31% |
| NOVO HOLDINGS A/S | 10/24/2024 | 1.00 M | $51.10 M | 0.00% | 1.25% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 11/14/2024 | 943,611 | $48.22 M | -21.40% | 1.18% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 908,149 | $46.41 M | 201.84% | 1.13% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 11/14/2024 | 834,912 | $42.66 M | 103.47% | 1.04% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 787,028 | $40.22 M | 21.23% | 0.98% |
| LORD, ABBETT & CO. LLC | 11/14/2024 | 746,118 | $38.13 M | -15.97% | 0.93% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2024 | 735,088 | $37.56 M | 0.00% | 0.92% |
| GW&K INVESTMENT MANAGEMENT, LLC | 11/07/2024 | 732,892 | $37.45 M | 94.06% | 0.92% |
| PERCEPTIVE ADVISORS LLC | 11/14/2024 | 724,698 | $37.03 M | -50.91% | 0.90% |
| MORGAN STANLEY | 11/14/2024 | 665,599 | $34.01 M | -20.63% | 0.83% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 655,418 | $33.49 M | 9.78% | 0.82% |
| ENSIGN PEAK ADVISORS, INC | 11/14/2024 | 616,837 | $31.52 M | 0.10% | 0.77% |
| BIOIMPACT CAPITAL LLC | 11/13/2024 | 525,845 | $26.87 M | -5.62% | 0.66% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 514,194 | $26.28 M | 11.11% | 0.64% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 11/08/2024 | 491,381 | $25.11 M | -10.04% | 0.61% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 490,725 | $25.08 M | -24.91% | 0.61% |
| FISHER ASSET MANAGEMENT, LLC | 11/12/2024 | 482,099 | $24.64 M | 8.42% | 0.60% |
| FIERA CAPITAL CORP | 11/01/2024 | 466,075 | $23.82 M | -2.98% | 0.58% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 426,913 | $21.82 M | -27.50% | 0.53% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 400,000 | $20.44 M | -22.33% | 0.50% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 392,196 | $20.04 M | -28.27% | 0.49% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 386,886 | $19.77 M | 3,361.14% | 0.48% |
| VOYA INVESTMENT MANAGEMENT LLC | 11/14/2024 | 377,589 | $19.29 M | 64.23% | 0.47% |
| FIRST TURN MANAGEMENT, LLC | 11/07/2024 | 353,376 | $18.06 M | -4.31% | 0.44% |
| VICTORY CAPITAL MANAGEMENT INC | 11/05/2024 | 343,344 | $17.54 M | 51.46% | 0.43% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 311,940 | $15.94 M | -19.28% | 0.39% |
| DUQUESNE FAMILY OFFICE LLC | 11/14/2024 | 309,000 | $15.79 M | 0.00% | 0.39% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2024 | 300,000 | $15.33 M | -25.00% | 0.37% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 289,400 | $14.79 M | 0.00% | 0.36% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 287,794 | $14.71 M | -26.38% | 0.36% |
| JPMORGAN CHASE & CO | 11/08/2024 | 285,956 | $14.61 M | 0.31% | 0.36% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 278,073 | $14.21 M | -8.88% | 0.35% |
| INVESCO LTD. | 11/12/2024 | 255,300 | $13.05 M | 40.58% | 0.32% |
Crinetics Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CRNX shares?
During the previous two years, 262 institutional investors and hedge funds held shares of Crinetics Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 6.55 M
DRIEHAUS CAPITAL MANAGEMENT LLC: 5.89 M
PRICE T ROWE ASSOCIATES INC /MD/: 4.94 M
WELLINGTON MANAGEMENT GROUP LLP: 4.46 M
EcoR1 Capital, LLC: 4.29 M
STATE STREET CORP: 2.84 M
-
What percentage of Crinetics Pharmaceuticals, Inc. stock is owned by institutional investors?
105.51% of Crinetics Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at CRNX ?
Institutional investors have bought a total of 78.92 M shares in the last 24 months. This purchase volume represents approximately $4.44 B in transactions.